Company page

Lantern Pharma Inc.

Lantern Pharma Inc. is a public company traded under the ticker LTRN in the American market. With a market capitalization of approximately $43.9 million, the company focuses on developing targeted therapies for cancer treatment. Lantern Pharma utilizes advanced artificial intelligence and machine learning to enhance drug discovery and development processes.